Patents by Inventor Yuedong ZHOU

Yuedong ZHOU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUND BASED ON QUINAZOLINE-SUBSTITUTED GLUTARIMIDE SKELETON AND USE THEREOF
    Publication number: 20240425475
    Abstract: The present disclosure provides a compound of Formula (I) or salts, enantiomers, stereoisomers, solvates, or polymorphs thereof, and uses thereof. The present disclosure also provides pharmaceutical compositions comprising, as an active ingredient, the compound of Formula (I) or salts, enantiomers, stereoisomers, solvates, or polymorphs thereof, and uses thereof. The series of compounds designed and synthesized in the present disclosure can effectively prevent and/or treat diseases or disorders associated with the cereblon protein.
    Type: Application
    Filed: August 14, 2024
    Publication date: December 26, 2024
    Applicant: GLUETACS THERAPEUTICS (SHANGHAI) CO., LTD.
    Inventors: Xiaobao Yang, Renhong Sun, Baoyin Zhao, Yuedong Zhou, Yan Li, Yinbo Ren
  • ALK PROTEIN REGULATOR AND ANTI-TUMOR APPLICATION THEREOF
    Publication number: 20220257776
    Abstract: A compound of general formula (I), a compound of general formula (III) and anti-tumor applications thereof. A series of compounds designed and synthesized have a wide range of pharmacological activities, have the function of degrading specific proteins and/or inhibiting activity, and can be used in related tumor and cancer treatments.
    Type: Application
    Filed: June 11, 2020
    Publication date: August 18, 2022
    Inventors: Xiaobao YANG, Biao JIANG, Xiaoling SONG, Ning SUN, Chaowei REN, Ying KONG, Jianshui ZHANG, Jinju CHEN, Yan LI, Yuedong ZHOU
  • Dihydropyrimido fused ring derivative as HBV inhibitor
    Patent number: 9938301
    Abstract: Disclosed is a dihydropyrimido fused ring derivative as a HBV inhibitor, and in particular relates to a compound shown as formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 27, 2015
    Date of Patent: April 10, 2018
    Assignee: QILU PHARMACEUTICAL CO., LTD.
    Inventors: Haiying He, Kai Zhou, Hua Qin, Xiaolin Li, Yuedong Zhou, Xiaofei Wang, Xuemei Chi, Jian Li, Shuhui Chen
  • DIHYDROPYRIMIDO LOOP DERIVATIVE AS HBV INHIBITOR
    Publication number: 20170197986
    Abstract: Disclosed is a dihydropyrimido fused ring derivative as a HBV inhibitor, and in particular relates to a compound shown as formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 27, 2015
    Publication date: July 13, 2017
    Applicant: MEDSHINE DISCOVERY INC.
    Inventors: Haiying HE, Kai ZHOU, Hua QIN, Xiaolin LI, Yuedong ZHOU, Xiaofei WANG, Xuemei CHI, Jian LI, Shuhui CHEN